The core of the global bio industry remains in Boston and South San Francisco, but emerging bio clusters in Beijing, London and Seattle are rapidly expanding their influence. Since COVID‑19, nations have promoted biotech as a strategic industry, leading to a multipolar shift in global bio hubs. According to CBRE’s Global Life Sciences Atlas, laboratory and R&D space under construction worldwide last year surpassed 35 million square feet (about 3.25 million m²).
分析2026年9月3日•1分で読めます
Emerging Bio Clusters Expand as Global R&D Space Tops 35M Sq Ft
CBRE reports worldwide biotech R&D construction exceeds 35 million sq ft, as new clusters in Beijing, London and Seattle grow alongside Boston and San Francisco.
PharmaCountryチームがまとめました · 出典： KPA News
評価
(0)
(0)
(0)
(0)
(0)
評価を残す